Gregory Mayes
Chief Executive Officer at Reunion Neuroscience, Inc.
Profile
Gregory T.
Mayes was the founder of Engage Therapeutics, Inc. (founded in 2017) where he held the title of President, Chief Executive Officer & Director from 2017 to 2020.
He is currently the President, Chief Executive Officer & Director at Antios Therapeutics, Inc. (since 2020), Reunion Neuroscience, Inc. (since 2022), and Epilepsy Foundation (since 2021).
He is also a Director at Receptor Life Sciences, Inc. (since 2020).
Mr. Mayes has held positions as an Independent Director at OncoSec Medical, Inc. (2018-2019), Director at Advaxis, Inc. (2013-2017), Independent Director at AVEO Pharmaceuticals, Inc. (2019-2023), Chief Compliance Officer & VP-General Counsel at ImClone LLC (2004-2010), Secretary at Unigene Laboratories, Inc. (2010-2013), and Senior Counsel at AstraZeneca Pharmaceuticals LP (2001-2004).
He is a Member of the New Jersey State Bar Association, Kent Place School, Inc., City of Summit (New Jersey) Health Board, and BioNJ, Inc. Mr. Mayes received his undergraduate degree from Syracuse University in 1991 and his graduate degree from Temple University Beasley School of Law.
Gregory Mayes active positions
| Companies | Position | Start |
|---|---|---|
New Jersey State Bar Association
 New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services New Jersey State Bar Association operates as a not-for-profit organization. It educates the public to enhance awareness of the legal system. The company was founded in June 1899 and is headquartered in New Brunswick, NJ. | Corporate Officer/Principal | - |
| City of Summit (New Jersey) | Corporate Officer/Principal | - |
Kent Place School, Inc.
 Kent Place School, Inc. Other Consumer ServicesConsumer Services Kent Place School, Inc. operates as girl's day school. The school operates preschool, primary school, middle school and upper school. The school was founded in 1894 and is headquartered in Summit, NJ. | Director/Board Member | - |
Receptor Life Sciences, Inc.
 Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Director/Board Member | 2020-11-10 |
Antios Therapeutics, Inc.
 Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Chief Executive Officer | 2020-11-30 |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Director/Board Member | 2021-07-12 |
Reunion Neuroscience, Inc.
 Reunion Neuroscience, Inc. BiotechnologyHealth Technology Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada. | Chief Executive Officer | 2022-09-27 |
Former positions of Gregory Mayes
| Companies | Position | End |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | Director/Board Member | 2023-01-18 |
Engage Therapeutics, Inc.
 Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Founder | 2020-07-31 |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Training of Gregory Mayes
| Syracuse University | Undergraduate Degree |
| Temple University Beasley School of Law | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ONCOSEC MEDICAL INCORPORATED | Health Services |
 | Health Technology |
| Private companies | 14 |
|---|---|
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Health Technology |
Unigene Laboratories, Inc.
 Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Epilepsy Foundation provides welfare services. It offers therapies to stop seizures, wellness institute and legal issue services. The company was founded in 1967 and is headquartered in Landover, MD. | Commercial Services |
New Jersey State Bar Association
New Jersey State Bar Association Miscellaneous Commercial ServicesCommercial Services New Jersey State Bar Association operates as a not-for-profit organization. It educates the public to enhance awareness of the legal system. The company was founded in June 1899 and is headquartered in New Brunswick, NJ. | Commercial Services |
BioNJ, Inc.
 BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Commercial Services |
Kent Place School, Inc.
Kent Place School, Inc. Other Consumer ServicesConsumer Services Kent Place School, Inc. operates as girl's day school. The school operates preschool, primary school, middle school and upper school. The school was founded in 1894 and is headquartered in Summit, NJ. | Consumer Services |
Receptor Life Sciences, Inc.
Receptor Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Receptor Life Sciences, Inc. operates as a pharmaceutical development company. It offer treatment of pain, central nervous systems, metabolic disorders, and gastrointestinal disorders. The company was founded in 2015 and is headquartered in Seattle, WA. | Health Technology |
Engage Therapeutics, Inc.
Engage Therapeutics, Inc. BiotechnologyHealth Technology Engage Therapeutics, Inc. engages in the development of rescue therapy for uncontrolled epileptic seizures. The company was founded by Gregory T. Mayes III and Jouko Isojarvi in 2017 and is headquartered in Summit, NJ. | Health Technology |
Antios Therapeutics, Inc.
Antios Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Antios Therapeutics, Inc. operates as a biopharmaceutical company devoted to developing therapies for viral diseases. The company was founded by Abel De La Rosa, Doug Mayers and Idean Marvasty on October 30, 2018 and is headquartered in Atlanta, GA. | Health Technology |
| City of Summit (New Jersey) | Government |
- Stock Market
- Insiders
- Gregory Mayes